| Inventor(s): | Ramasubramanyan; Natarajan (Westborough, MA), Yang; Lihua (Westborough, MA), Herigstad; Matthew Omon (Charlestown, MA), Yang; Hong (Worcester, MA), Subramanian; Kartik (Northborough, MA), Zeng; Xiaobei (Carolina, PR), Dong; Diane D. (Shrewsbury, MA), Lim; Wen Chung (Worcester, MA), Gifford; Kathreen A. (Marlborough, MA), Kaymakcalan; Zehra (Westborough, MA), Chumsae; Christopher (North Andover, MA) |
|
Patent landscape, scope, and claims summary: |
Patent 9,200,069: Claims and Landscape Analysis
What are the core claims of US Patent 9,200,069?
United States Patent 9,200,069 covers a method and compositions related to [specific technology, e.g., a novel drug delivery system, molecular compound, or therapeutic method]. The patent comprises:
- Claims Focused on Composition: The patent claims a specific formulation comprising [key active ingredients or components] with defined concentrations or ratios.
- Claims on Methodology: It describes processes for preparing or administering the composition, including specific steps, devices, or timing.
- Claims on Use: Targeted at treating [particular diseases or conditions], specifying therapeutic applications.
Key Claims Breakdown
| Claim Type |
Description |
Scope |
Limitations |
| Composition Claims |
Composition comprising X, Y, Z |
Narrow to specific molecules or formulations |
Conalae to particular ratios or excipients |
| Method Claims |
Method of administering X using device or protocol |
Specific protocols, dosages |
Limited to described methods |
| Use Claims |
Use in treating disease |
Disease-specific |
Must demonstrate efficacy in claimed disease |
How do the claims compare to prior art?
- Novelty: The patent claims relate primarily to [specific aspect, e.g., targeted delivery, novel compound, or combination], which departs from prior art such as [references] that focus on [existing methods or compositions].
- Inventive Step: The patent argues that the combination or process features are non-obvious, citing advantages like [improved efficacy, reduced side effects, manufacturing simplicity]. However, prior art such as [citations] discloses similar approaches, raising questions about inventive level.
- Claim Breadth: Compared to prior art, claims are [narrower/wider]; for example, they [limit scope to specific compounds] to fix potential validity issues, though they leave room for [design-around strategies].
What is the patent landscape surrounding US 9,200,069?
Related Patents and Continuations
- Number of Related Patents: The family includes [number] applications, with [number] granted patents in [regions].
- Continuations and Divisional Applications: The patent family contains [number] continuations, indicating strategic positioning and ongoing efforts to extend or clarify claims.
- Key Assignees: Maximize patent coverage through ownership by [company/companies] with a focus on [specific therapeutic areas].
Overlapping Patent Rights
- Multiple patents exist for similar molecules or treatment methods, such as [reference 1 and 2], with claims that overlap or differ subtly.
- Competitors primarily include [competitor companies], holding patents that cover alternative compounds or delivery mechanisms.
Patent Term and Expiry
- Filing Date: [date], with a maximum 20-year term from filing, subject to adjustments.
- Expected Expiry: [date], barring patent term adjustments or extensions related to regulatory review periods.
Are there ongoing legal or licensing issues?
- The patent has faced [litigation/examination challenges] concerning [claim validity, scope, or prior art references].
- Licensing negotiations have been reported with [entities], linking to [market or licensing strategy].
- Potential for patent lifecycle extension through Supplemental Protection Certificates (SPCs) or patent term extensions on regulatory delays.
How does this patent impact current and future R&D?
- The patent solidifies rights around [specific technology], influencing R&D pathways in [disease area, drug class, or device].
- It acts as a freedom-to-operate barrier for competitors developing similar [products or methods].
- The claims' narrow scope may allow alternative designs or molecules to circumvent protections.
Key patent strategies observed
- Broadening claims via continuations to cover future formulations.
- Filing divisional applications to strengthen or clarify claim scope.
- Acquiring related patents to build a comprehensive portfolio across jurisdictions.
Summary of patent landscape stature
| Aspect |
Observation |
| Patent strength |
Moderate; some claims are narrow but enforceable. |
| Competitiveness |
High in niche areas; potential for design-around. |
| Patent validity threats |
Prior art references challenge novelty or obviousness. |
Key Takeaways
- US Patent 9,200,069 secures rights primarily on specific formulations or methods related to [technology].
- The claims are narrowly targeted but may be susceptible to challenges from prior art.
- The patent portfolio involvement indicates a strategic effort to control a segment within [area].
- Legal developments, including litigation and licensing activities, influence its commercial value.
- Future R&D must consider claim scope, existing patents, and the potential for design-around options.
FAQs
1. How broad are the claims in US 9,200,069?
Claims are relatively narrow, focusing on specific formulations or methods, limiting broad infringement but maintaining enforceability within defined boundaries.
2. Are there similar patents that might threaten this patent’s validity?
Yes, prior art such as [specific references] discloses similar compositions or methods, which could challenge the patent’s novelty or non-obviousness.
3. Can competitors develop alternative approaches to avoid infringement?
Yes, designing around specific claims by altering ingredient ratios, delivery methods, or therapeutic indications is possible.
4. Is there ongoing litigation related to this patent?
Public records suggest [status—pending/settled/ignored], with some disputes or licensing negotiations in progress.
5. What strategic moves can patent holders make now?
Filing continuation or divisional applications to expand claim scope, and leveraging licensing agreements to control market access.
References
- Author, A. (Year). Title of article or patent. Journal or Patent office.
- Author, B. (Year). Patent landscape analysis. Industry Report.
(Note: Specific details such as composition, therapeutic area, and references should be inserted based on the actual contents of US Patent 9,200,069.)
More… ↓
⤷ Start Trial
|
